MedPath

Incidental Coronary Calcification Quality Improvement Project

Not Applicable
Conditions
Coronary Artery Disease
Atherosclerotic Cardiovascular Disease
Interventions
Other: Notification
Registration Number
NCT04789278
Lead Sponsor
Stanford University
Brief Summary

This is a multi-center, randomized quality improvement project. At least 200 statin-naïve patients without a history of atherosclerotic cardiovascular disease with incidental coronary artery calcium (CAC) on a prior non-gated chest CT will be enrolled across the Stanford Healthcare System and the Palo Alto Veteran's Affairs Healthcare System. Patients will be randomized in a 1:1 fashion to notification or usual care arms. The primary aim of this project is to estimate the increase in 6-month statin prescription among statin-naïve patients without a history of atherosclerotic cardiovascular disease with incidental CAC on a non-gated chest CT who are randomized to receive notification of their findings vs. usual care.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
173
Inclusion Criteria
  • Non-gated chest CT between 2014-2019
  • The presence of CAC confirmed by manual review by an experienced radiologist
  • Stanford affiliated primary care provider or endocrinologist for Stanford healthcare system patients and VA primary care provider for VA patients with at least 1 encounter since 2018
Read More
Exclusion Criteria
  • Current or prior statin or PCSK9 inhibitor therapy
  • Prior diagnosis of ASCVD (coronary artery disease, peripheral arterial disease, cerebrovascular disease, coronary/peripheral revascularization)
  • Prior coronary imaging (cardiac CT, invasive coronary angiography)
  • Dementia
  • Metastatic cancer or active cancer undergoing chemotherapy
  • History of medical nonadherence
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NotificationNotificationPatients randomized to notification will receive a message sent by either the electronic health record (EHR) patient portal or postal mail that will inform them of the CAC identified on their previous chest CT. It will provide an overview of CAC, an image of their chest CT, and a recommendation that they discuss this finding with their clinician. These clinicians will be notified of these findings via an earlier EHR message. Any treatment decisions will be made by the patient and their clinician. Patients randomized to notification who are not prescribed a statin medication and do not have a documented discussion regarding statin therapy within three months will be sent a second message at that time. Their primary care providers will receive a second EHR message concurrently.
Primary Outcome Measures
NameTimeMethod
Rate of Statin PrescriptionWithin 6 months

Proportion of patients prescribed a statin

Secondary Outcome Measures
NameTimeMethod
Number of primary Care Clinical Encounters6 months
Number of Cardiology Referrals6 months
LDL Cholesterol Level6 months
Systolic Blood Pressure6 months
Hemoglobin A1c Level6 months
Statin Intensity6 months

Proportion of patients prescribed a high intensity, intermediate intensity, and low intensity statin

HDL Cholesterol Level6 months
Rate of Aspirin Prescription6 months

Proportion of patients prescribed aspirin

Total Cholesterol Level6 months
Number of Cardiovascular Diagnostic Tests6 months
Triglyceride Level6 months
Number of Hypertension Medications6 months
Body Mass Index6 months
Pooled cohort equations estimated 10-year risk of atherosclerotic cardiovascular disease6 months

Trial Locations

Locations (1)

Stanford Hospital & Clinics

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath